These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26864352)

  • 61. A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia.
    Pandina G; Lane R; Gopal S; Gassmann-Mayer C; Hough D; Remmerie B; Simpson G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):218-26. PubMed ID: 21092748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
    Möller HJ
    Drugs; 2007; 67(11):1541-66. PubMed ID: 17661527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy.
    Baune BT
    Curr Med Res Opin; 2024 Jan; 40(1):87-96. PubMed ID: 37999650
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
    Llorca PM; Abbar M; Courtet P; Guillaume S; Lancrenon S; Samalin L
    BMC Psychiatry; 2013 Dec; 13():340. PubMed ID: 24359031
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.
    Detke HC; McDonnell DP; Brunner E; Zhao F; Sorsaburu S; Stefaniak VJ; Corya SA
    BMC Psychiatry; 2010 Jun; 10():43. PubMed ID: 20537128
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-acting injectable antipsychotics: an underutilized treatment option.
    Heres S
    J Clin Psychiatry; 2014 Nov; 75(11):1263-5. PubMed ID: 25470087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.
    Potkin S; Bera R; Zubek D; Lau G
    BMC Psychiatry; 2013 Oct; 13():261. PubMed ID: 24131801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-acting Injectable Antipsychotics in First-episode Schizophrenia.
    Jeong HG; Lee MS
    Clin Psychopharmacol Neurosci; 2013 Apr; 11(1):1-6. PubMed ID: 23678347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications.
    Uchida H; Suzuki T
    J Clin Psychopharmacol; 2014 Dec; 34(6):728-35. PubMed ID: 24781442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reducing the stigma of long acting injectable antipsychotics - current concepts and future developments.
    Taylor DM; Velaga S; Werneke U
    Nord J Psychiatry; 2018 Sep; 72(sup1):S36-S39. PubMed ID: 30688170
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis.
    Lee J; Oh S; Moon SY; Loh SK; Kim M; Lee TY; Kwon JS
    Int Clin Psychopharmacol; 2024 Jul; 39(4):250-256. PubMed ID: 37982292
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?
    Stroup TS
    J Clin Psychiatry; 2014 Nov; 75(11):1261-2. PubMed ID: 25470086
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder.
    Orsolini L; Biagiotti SP; Martino LM; Volpe U
    Asian J Psychiatr; 2024 Apr; 94():103992. PubMed ID: 38461611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Aripiprazole long-acting for the maintenance treatment of schizophrenia.].
    Samalin L; Charpeaud T; Llorca PM
    Encephale; 2014 Dec; 40(6):487-494. PubMed ID: 25453734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Neuropsychiatr Dis Treat; 2015; 11():2299-307. PubMed ID: 26366084
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.
    Kane JM; Mychaskiw MA; Lim S; Suett M; Tian M; Rubio JM
    J Clin Psychiatry; 2023 Apr; 84(3):. PubMed ID: 37074300
    [No Abstract]   [Full Text] [Related]  

  • 77. Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia.
    Wilson M; Gutierrez B; Offord SJ; Blanchette CM; Eramo A; Earnshaw S; Kamat SA
    Drugs Context; 2016; 5():212273. PubMed ID: 27114739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes.
    Barnes TR; Drake RJ; Dunn G; Hayhurst KP; Jones PB; Lewis SW
    Br J Psychiatry; 2013 Sep; 203(3):215-20. PubMed ID: 23888001
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.
    Peters-Strickland T; Baker RA; McQuade RD; Jin N; Eramo A; Perry P; Johnson BR; Duca A; Sanchez R
    NPJ Schizophr; 2015; 1():15039. PubMed ID: 27336044
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-acting injectable antipsychotics: focus on olanzapine pamoate.
    Lindenmayer JP
    Neuropsychiatr Dis Treat; 2010 Jun; 6():261-7. PubMed ID: 20628628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.